Covered recipient · General Payments record
DANIEL A SCHWARTZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$24,269.91
- Reported across 973 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $982.83 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $429.22 | 7 |
| ABBVIE INC. | $152.57 | 6 |
| Lilly USA, LLC | $145.05 | 7 |
| GlaxoSmithKline, LLC. | $121.84 | 1 |
| Astellas Pharma US Inc | $52.34 | 2 |
| Novo Nordisk AS | $45.40 | 2 |
| Acerta Pharma LLC | $36.41 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.56 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125151462 | CMS |
| Abbott Laboratories | $171.74 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125151464 | CMS |
| Abbott Laboratories | $20.27 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125151466 | CMS |
| Abbott Laboratories | $20.27 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125151468 | CMS |
| Abbott Laboratories | $17.57 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125151470 | CMS |
| Abbott Laboratories | $20.27 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125151472 | CMS |
| Abbott Laboratories | $161.54 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125151474 | CMS |
| ABBVIE INC. | $16.94 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044372 | CMS |
| ABBVIE INC. | $23.66 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044374 | CMS |
| ABBVIE INC. | $23.63 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044376 | CMS |
| ABBVIE INC. | $31.20 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044378 | CMS |
| ABBVIE INC. | $26.32 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044380 | CMS |
| ABBVIE INC. | $30.82 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106044382 | CMS |
| Astellas Pharma US Inc | $32.63 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139302562 | CMS |
| Astellas Pharma US Inc | $19.71 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139445566 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.93 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104420639 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.48 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104342220 | CMS |
| GlaxoSmithKline, LLC. | $121.84 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116381562 | CMS |
| Lilly USA, LLC | $19.38 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136116804 | CMS |
| Lilly USA, LLC | $8.58 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119262 | CMS |
| Lilly USA, LLC | $18.52 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136127785 | CMS |
| Lilly USA, LLC | $20.72 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136139519 | CMS |
| Lilly USA, LLC | $27.17 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119264 | CMS |
| Lilly USA, LLC | $28.29 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136127787 | CMS |
| Lilly USA, LLC | $22.39 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119266 | CMS |
| Novo Nordisk Inc | $21.85 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096778770 | CMS |
| Novo Nordisk Inc | $23.55 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097677100 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.